Genky DrugStores Co., Ltd. (9267.T)
JPY 3190.0
(1.11%)
JPY 3190.0
(1.11%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 9.01 Billion JPY | 34.39% |
| 2022 | 6.7 Billion JPY | 18.22% |
| 2021 | 5.67 Billion JPY | -9.85% |
| 2020 | 6.29 Billion JPY | 44.99% |
| 2019 | 4.34 Billion JPY | 7.29% |
| 2018 | 4.04 Billion JPY | -1.99% |
| 2017 | 4.12 Billion JPY | 7.27% |
| 2016 | 3.84 Billion JPY | 44.96% |
| 2015 | 2.65 Billion JPY | -3.05% |
| 2014 | 2.73 Billion JPY | 44.03% |
| 2013 | 1.9 Billion JPY | 112.1% |
| 2012 | 896.55 Million JPY | -46.37% |
| 2011 | 1.67 Billion JPY | 23.75% |
| 2010 | 1.35 Billion JPY | 40.08% |
| 2009 | 964.43 Million JPY | 1.47% |
| 2008 | 950.45 Million JPY | -18.88% |
| 2007 | 1.17 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 2.27 Billion JPY | -9.8% |
| 2023 Q3 | 2.1 Billion JPY | -11.13% |
| 2023 FY | 9.01 Billion JPY | 34.39% |
| 2023 Q2 | 2.37 Billion JPY | 17.72% |
| 2023 Q1 | 2.01 Billion JPY | 3.28% |
| 2023 Q4 | 2.52 Billion JPY | 19.59% |
| 2022 Q2 | 1.78 Billion JPY | 12.37% |
| 2022 Q3 | 1.39 Billion JPY | -21.69% |
| 2022 Q4 | 1.95 Billion JPY | 39.96% |
| 2022 Q1 | 1.58 Billion JPY | 6.93% |
| 2022 FY | 6.7 Billion JPY | 18.22% |
| 2021 Q3 | 1.27 Billion JPY | 7.49% |
| 2021 FY | 5.67 Billion JPY | -9.85% |
| 2021 Q1 | 1.73 Billion JPY | 5.45% |
| 2021 Q2 | 1.18 Billion JPY | -31.91% |
| 2021 Q4 | 1.48 Billion JPY | 16.46% |
| 2020 Q4 | 1.64 Billion JPY | 16.42% |
| 2020 Q3 | 1.41 Billion JPY | -6.22% |
| 2020 Q2 | 1.5 Billion JPY | -12.29% |
| 2020 Q1 | 1.72 Billion JPY | -9.36% |
| 2020 FY | 6.29 Billion JPY | 44.99% |
| 2019 Q2 | 506.73 Million JPY | -17.38% |
| 2019 Q4 | 1.89 Billion JPY | 43.56% |
| 2019 FY | 4.34 Billion JPY | 7.29% |
| 2019 Q1 | 613.32 Million JPY | -47.07% |
| 2019 Q3 | 1.32 Billion JPY | 161.03% |
| 2018 Q3 | 896.86 Million JPY | 7.95% |
| 2018 Q4 | 1.15 Billion JPY | 29.21% |
| 2018 FY | 4.04 Billion JPY | -1.99% |
| 2018 Q1 | 1.16 Billion JPY | -10.4% |
| 2018 Q2 | 830.82 Million JPY | -28.4% |
| 2017 Q1 | 1.07 Billion JPY | -14.9% |
| 2017 Q4 | 1.29 Billion JPY | 48.96% |
| 2017 Q3 | 869.32 Million JPY | -2.67% |
| 2017 FY | 4.12 Billion JPY | 7.27% |
| 2017 Q2 | 893.17 Million JPY | -16.63% |
| 2016 Q4 | 1.25 Billion JPY | 86.56% |
| 2016 Q1 | 1.06 Billion JPY | 6.35% |
| 2016 Q2 | 854.26 Million JPY | -19.5% |
| 2016 Q3 | 674.76 Million JPY | -21.01% |
| 2016 FY | 3.84 Billion JPY | 44.96% |
| 2015 FY | 2.65 Billion JPY | -3.05% |
| 2015 Q4 | 997.83 Million JPY | 95.68% |
| 2015 Q3 | 509.94 Million JPY | -4.15% |
| 2015 Q2 | 532.01 Million JPY | -13.56% |
| 2015 Q1 | 615.47 Million JPY | -25.41% |
| 2014 Q4 | 825.1 Million JPY | 19.44% |
| 2014 FY | 2.73 Billion JPY | 44.03% |
| 2014 Q1 | 667.94 Million JPY | -25.92% |
| 2014 Q2 | 555.06 Million JPY | -16.9% |
| 2014 Q3 | 690.8 Million JPY | 24.46% |
| 2013 FY | 1.9 Billion JPY | 112.1% |
| 2013 Q2 | 298.76 Million JPY | 11.03% |
| 2013 Q3 | 432.07 Million JPY | 44.62% |
| 2013 Q4 | 901.67 Million JPY | 108.69% |
| 2013 Q1 | 269.09 Million JPY | -43.42% |
| 2012 FY | 896.55 Million JPY | -46.37% |
| 2012 Q2 | -10.64 Million JPY | -103.91% |
| 2012 Q4 | 475.6 Million JPY | 199.0% |
| 2012 Q1 | 272.53 Million JPY | -50.84% |
| 2012 Q3 | 159.06 Million JPY | 1594.52% |
| 2011 Q4 | 554.37 Million JPY | 45.56% |
| 2011 Q3 | 380.85 Million JPY | 0.35% |
| 2011 Q2 | 379.51 Million JPY | 6.27% |
| 2011 Q1 | 357.13 Million JPY | 5.94% |
| 2011 FY | 1.67 Billion JPY | 23.75% |
| 2010 Q2 | 177.1 Million JPY | -53.99% |
| 2010 Q3 | 451.83 Million JPY | 155.12% |
| 2010 FY | 1.35 Billion JPY | 40.08% |
| 2010 Q1 | 384.9 Million JPY | 44.09% |
| 2010 Q4 | 337.11 Million JPY | -25.39% |
| 2009 Q2 | 181.25 Million JPY | -50.35% |
| 2009 FY | 964.43 Million JPY | 1.47% |
| 2009 Q4 | 267.13 Million JPY | 76.91% |
| 2009 Q1 | 365.05 Million JPY | 26.73% |
| 2009 Q3 | 150.99 Million JPY | -16.69% |
| 2008 Q3 | 210.75 Million JPY | -13.27% |
| 2008 Q2 | 243.01 Million JPY | 16.49% |
| 2008 Q1 | 208.61 Million JPY | 0.0% |
| 2008 FY | 950.45 Million JPY | -18.88% |
| 2008 Q4 | 288.06 Million JPY | 36.68% |
| 2007 FY | 1.17 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| HEARTSEED INC | -1.45 Billion JPY | 717.698% |
| Cawachi Limited | 7.6 Billion JPY | -18.616% |
| Pharmarise Holdings Corporation | 916 Million JPY | -884.279% |
| Qol Holdings Co., Ltd. | 8.32 Billion JPY | -8.3% |
| MatsukiyoCocokara & Co. | 75.7 Billion JPY | 88.091% |
| Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 79.145% |
| Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 55.426% |
| NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 1.4% |
| COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 71.379% |
| Tsuruha Holdings Inc. | 49.2 Billion JPY | 81.677% |
| Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | -341.096% |
| Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -550.975% |
| Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 51.446% |
| Medical System Network Co., Ltd. | 3.83 Billion JPY | -135.282% |
| Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | -140.17% |
| Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 75.382% |
| YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | -73.019% |
| Astena Holdings Co., Ltd. | 1.12 Billion JPY | -699.225% |
| Ain Holdings Inc. | 20.43 Billion JPY | 55.873% |
| Sundrug Co.,Ltd. | 40.99 Billion JPY | 78.008% |